title: Should we rely on OCT to assess the improvements of new generation drug-eluting stents?
authors: Heart Institute (InCor), University of São Paulo Medical School, & Hospital Sirio-Libanes, Av. Dr. Eneas de Carvalho Aguiar, 44, Bloco I, 3º andar, Hemodinâmica, São Paulo, SP 05403-000, Brazil. pedro.lemos@incor.usp.br
authors: Pedro A
authors: PA
authors: Lemos
mesh_terms: D002317:Cardiovascular Agents / Q000008:administration & dosage*; D003324:Coronary Artery Disease / Q000628:therapy*; D003331:Coronary Vessels / Q000473:pathology*; D054855:Drug-Eluting Stents; D005260:Female; D006801:Humans; D008297:Male; D058426:Neointima; D062645:Percutaneous Coronary Intervention / Q000295:instrumentation*; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives*; D041623:Tomography, Optical Coherence
chemical_list: D002317:Cardiovascular Agents; C489443:zotarolimus; D020123:Sirolimus